Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas
- PMID: 15235871
- DOI: 10.1007/s00535-003-1340-3
Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas
Abstract
Background: The point mutations occurring in codons 12 and 13 of the Ki- ras gene are useful genetic markers to identify intratumoral heterogeneity. A single tumor crypt, which consists of monoclonal cells, can be obtained using the crypt isolation method. Ki- ras gene mutations have been examined using the crypt isolation method to determine whether multiclonarity is present within the same tumor.
Methods: Ki- ras gene mutations were analyzed using a crypt isolation technique coupled with polymerase chain reaction and direct sequencing in 21 sporadic colorectal carcinomas. The specimens were divided into two groups: a representative sample, which was composed of more than 50 tumor crypts, and a single tumor crypt sample. The latter consisted of 10 single tumor crypts, which were obtained from the same tumor separately.
Results: Ki- ras gene mutations were found in 11 of 21 representative samples and in 12 of 21 single tumor crypt samples. In the 11 samples with Ki- ras mutation, Ki- ras mutations were also found in most single tumor crypts. Among the 12 base substitutions found, G:C to A:T transitions were the most commonly observed. There were no differences between the two samples in the types of Ki- ras mutations found. One Ki- ras mutation that was not detected in the representative sample was observed in only a single tumor crypt.
Conclusions: Most carcinomas appear to have a homogeneous composition that may result from the successful progression of one of the clones having a Ki- ras mutation. Additional mutations in the Ki- ras gene were rarely observed in colorectal carcinomas.
Comment in
-
In which step does the K-ras mutation occur in colorectal carcinogenesis?J Gastroenterol. 2004 Jun;39(6):596-7. doi: 10.1007/s00535-004-1371-4. J Gastroenterol. 2004. PMID: 15235883 No abstract available.
Similar articles
-
Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.Oncol Rep. 2005 Sep;14(3):625-31. Oncol Rep. 2005. PMID: 16077965
-
A novel method for gene analysis of colorectal carcinomas using a crypt isolation technique.Lab Invest. 1996 May;74(5):933-40. Lab Invest. 1996. PMID: 8642788
-
Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester.Mol Carcinog. 1996 May;16(1):12-9. doi: 10.1002/(SICI)1098-2744(199605)16:1<12::AID-MC3>3.0.CO;2-Q. Mol Carcinog. 1996. PMID: 8634090
-
[Determination of the activated proto-oncogene (Ki-ras) in feces. A new laboratory analysis for early diagnosis of colorectal cancer].Tidsskr Nor Laegeforen. 1995 Oct 30;115(26):3266-70. Tidsskr Nor Laegeforen. 1995. PMID: 7482456 Review. Norwegian.
-
Exploring environmental causes of altered ras effects: fragmentation plus integration?Mol Carcinog. 2003 Feb;36(2):45-52. doi: 10.1002/mc.10093. Mol Carcinog. 2003. PMID: 12557259 Review.
Cited by
-
K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas.In Vivo. 2017 Jul-Aug;31(4):527-542. doi: 10.21873/invivo.11091. In Vivo. 2017. PMID: 28652417 Free PMC article. Review.
-
Colorectal cancer: genetics of development and metastasis.J Gastroenterol. 2006 Mar;41(3):185-92. doi: 10.1007/s00535-006-1801-6. J Gastroenterol. 2006. PMID: 16699851 Review.
-
A case of heterogeneous sensitivity to panitumumab in cetuximab-refractory colorectal adenocarcinoma metastases.Cancer Biol Ther. 2015;16(3):377-82. doi: 10.1080/15384047.2015.1004927. Cancer Biol Ther. 2015. PMID: 25695537 Free PMC article.
-
Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review.Oncologist. 2011;16(9):1239-49. doi: 10.1634/theoncologist.2011-0024. Epub 2011 Jul 8. Oncologist. 2011. PMID: 21742964 Free PMC article. Review.
-
Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy.Int J Colorectal Dis. 2011 Oct;26(10):1271-7. doi: 10.1007/s00384-011-1233-5. Epub 2011 May 15. Int J Colorectal Dis. 2011. PMID: 21573767
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical